MD Mednax Inc
Price (delayed)
$15.61
Market cap
$1.34B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.19
Enterprise value
$1.77B
Mednax, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of
Highlights
The quick ratio has grown by 21% year-on-year and by 2.9% since the previous quarter
Mednax's gross profit has increased by 8% YoY and by 6% from the previous quarter
The net income has dropped by 64% year-on-year but it has surged by 61% since the previous quarter
The company's EPS has shrunk by 63% YoY but it has surged by 61% QoQ
Key stats
What are the main financial stats of MD
Market
Valuations
Earnings
Shares outstanding
85.83M
Market cap
$1.34B
Enterprise value
$1.77B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.75
Price to sales (P/S)
0.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.88
Revenue
$2.01B
Gross profit
$454.34M
Operating income
-$59.01M
Net income
-$99.07M
EBIT
-$60.6M
EBITDA
-$28.37M
Free cash flow
$184.55M
Per share
Balance sheet
Liquidity
EPS
-$1.19
EPS diluted
-$1.19
Free cash flow per share
$2.21
Book value per share
$8.91
Revenue per share
$24.16
TBVPS
$10.78
Total assets
$2.15B
Total liabilities
$1.39B
Debt
$662.31M
Equity
$764.94M
Working capital
$205.5M
Debt to equity
0.87
Current ratio
1.47
Quick ratio
1.4
Net debt/EBITDA
-15.24
Margins
Efficiency
Dividend
EBITDA margin
-1.4%
Gross margin
22.6%
Net margin
-4.9%
Operating margin
-2.9%
Return on assets
-4.7%
Return on equity
-12.9%
Return on invested capital
-5.6%
Return on capital employed
-3.5%
Return on sales
-3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MD stock price
How has the Mednax stock price performed over time
Intraday
-9.4%
1 week
11.1%
1 month
11.5%
1 year
80.25%
YTD
18.98%
QTD
18.98%
Financial performance
How have Mednax's revenue and profit performed over time
Revenue
$2.01B
Gross profit
$454.34M
Operating income
-$59.01M
Net income
-$99.07M
Gross margin
22.6%
Net margin
-4.9%
MD's operating income has surged by 72% since the previous quarter
The operating margin has surged by 72% since the previous quarter
The net income has dropped by 64% year-on-year but it has surged by 61% since the previous quarter
The net margin has plunged by 63% YoY but it has soared by 61% from the previous quarter
Growth
What is Mednax's growth rate over time
Valuation
What is Mednax stock price valuation
P/E
N/A
P/B
1.75
P/S
0.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.88
The company's EPS has shrunk by 63% YoY but it has surged by 61% QoQ
The P/B is 46% above the last 4 quarters average of 1.2 but 2.8% below the 5-year quarterly average of 1.8
The equity is down by 10% YoY but it is up by 4.4% QoQ
The stock's price to sales (P/S) is 63% more than its last 4 quarters average of 0.4 but 19% less than its 5-year quarterly average of 0.8
Efficiency
How efficient is Mednax business performance
MD's return on equity has dropped by 95% year-on-year but it has surged by 60% since the previous quarter
The ROA has plunged by 81% YoY but it has soared by 61% from the previous quarter
The company's return on sales has surged by 74% QoQ
The ROIC has soared by 73% from the previous quarter
Dividends
What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MD.
Financial health
How did Mednax financials performed over time
The total assets is 55% greater than the total liabilities
The quick ratio has grown by 21% year-on-year and by 2.9% since the previous quarter
The company's current ratio rose by 19% YoY and by 3.5% QoQ
The debt is 13% less than the equity
The equity is down by 10% YoY but it is up by 4.4% QoQ
The debt has decreased by 6% YoY and by 3.1% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.